Piramal Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Analyst
Ashka Investment Managers
Equibles does not estimate personal net worth.
Sudarshan Padmabhan is recorded as Analyst at Ashka Investment Managers. Sudarshan Padmabhan has spoken on 2 earnings calls across 2 companies, most recently for Piramal Pharma Limited on October 28, 2026. Those appearances were for Piramal Pharma Limited and Innova Captab Limited. The companies whose calls Sudarshan Padmabhan spoke on are classified in the Healthcare sector.
“So my question is, you know, we have seen the on patent commercial manufacturing by improving and overall the innovation related work improving as a percentage of the business.”
“Sir, you know, with all the global issues happening, you know, how is the availability of raw materials? Do we have any issues in the supply chain that we have seen, which we, you know, are trying to address?”
Ashka Investment Managers
Analyst
Transcript header (unverified)
Piramal Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Innova Captab Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Piramal Pharma Limited
“Innova Captab Limited Q4 and FY '26 Earnings Conference Call”
Innova Captab Limited